Through quantitative measurement of the drug-resistant and sensitive lung cancer cells, this motif-targeting approach suggested potential drug-targeting proteins in the EGFR- and CK2-centred kinase–substrate network. The gene discussed is EGFR; the disease is lung carcinoma.